Department of Clinical Research, and Department of Diagnostic Pathology, National Hospital Organization Hakodate Hospital, Hakodate 041-8512, Japan.
Department of Diagnostic Pathology, Kainan Hospital Aichi Prefectural Welfare Federation of Agricultural Cooperatives, Yatomi 498-8502, Japan.
Endocr J. 2022 May 30;69(5):523-528. doi: 10.1507/endocrj.EJ21-0630. Epub 2021 Dec 1.
Recent progress in paraganglioma (PGL) revealed genotype-phenotype relationship, especially succinate dehydrogenase complex subunit B (SDHB) gene mutation-related to the extra-adrenal origin and metastasis. SDHB-immunohistochemistry can detect all types of SDH-subunit mutations, and is a useful tool to detect SDH-mutation tumors. PGLs usually occur along with sympathetic, and parasympathetic chains, however, colorectal paraganglioma is extremely rare. We have experienced one sigmoid colon PGL and one rectal PGL. These colorectal PGLs: a sigmoid colon PGL measuring 25 mm associated with a gastrointestinal stromal tumor (GIST) of the stomach, and a rectal PGL measuring 75 × 45 mm with elevated norepinephrine level were analyzed by immunohistochemistry for INSM1, chromogranin A, synaptophysin, tyrosine hydroxylase, dopamine-beta-hydroxylase, and SDHB and SDHA. The tumors were strongly positive for above markers, however, negative for SDHB. Both PGLs negative for SDHB immunohistochemistry were defined SDHB-deficient PGLs. Histologic grading of the PGLs by GAPP was well differentiated in sigmoid PGL versus poorly differentiated in rectal PGL. Although these PGLs were the same Stage II of TNM classification, the patient with sigmoid colon PGL had neither recurrence nor metastasis for 5 years after the operation, however, the patient with rectal PGL suffered the recurrent multiple metastases and expired 5 years after the operation. Herein, we compared these colorectal PGLs in regard to the patients' prognostic factors. Patient prognosis with these colorectal PGLs was mostly related to the tumor size and histologic grade under the same situation of SDH-deficiency.
近期副神经节瘤(PGL)的研究进展揭示了基因型-表型关系,尤其是琥珀酸脱氢酶复合物亚基 B(SDHB)基因突变与肾上腺外起源和转移相关。SDHB 免疫组化可检测所有类型的 SDH 亚基突变,是检测 SDH 突变肿瘤的有用工具。PGL 通常沿着交感和副交感神经链发生,然而,结直肠副神经节瘤极为罕见。我们曾遇到过一例乙状结肠 PGL 和一例直肠 PGL。这些结直肠 PGL:一个 25mm 的乙状结肠 PGL 伴有胃的胃肠道间质瘤(GIST),和一个 75×45mm 的直肠 PGL 伴有去甲肾上腺素水平升高,通过免疫组化分析 INSM1、嗜铬粒蛋白 A、突触素、酪氨酸羟化酶、多巴胺-β-羟化酶和 SDHB 和 SDHA。肿瘤对上述标志物均呈强阳性,然而 SDHB 为阴性。两个 PGL 对 SDHB 免疫组化均为阴性,定义为 SDHB 缺陷型 PGL。通过 GAPP 对 PGL 的组织学分级,乙状结肠 PGL 为高分化,而直肠 PGL 为低分化。尽管这些 PGL 的 TNM 分期均为 II 期,但乙状结肠 PGL 患者手术后 5 年内无复发或转移,而直肠 PGL 患者则出现多次复发转移,术后 5 年内死亡。在此,我们比较了这些结直肠 PGL 患者的预后因素。在相同的 SDH 缺陷情况下,患者的预后与肿瘤大小和组织学分级密切相关。